MUSC Ranked No. 1 in South Carolina
Author: Special to CH2
MUSC was named by U.S. News & World Report as the number one hospital in South Carolina and one of the country’s top 50 hospitals in the treatment of ear, nose and throat disorders; gynecology; nephrology; urology; and cancer. MUSC also was high performing in gastroenterology and GI surgery; geriatrics; neurology and neurosurgery; orthopedics; pulmonology; and rheumatology.
Patrick Cawley, M.D., MUSC Health CEO and MUSC vice president of health affairs, is proud of the rankings. “This year, we had numerous clinical teams reach national ranking, which reflects their commitment to deliver the highest level of quality and safe care for every patient,” he said. “These rankings reflect not just reputation, but patient outcomes, teaching the next generation of care providers and developing new innovations to improve health and health care leadership. We are honored to carry on this robust mission for South Carolina and the nation.”
For ENT, this latest ranking marks a break into the top 15 hospitals in the country. Paul Lambert, M.D., director of the MUSC Department of Otolaryngology and Head and Neck Surgery, was pleased that his division was again recognized as one of the nation’s leading ENT centers.
“We set a goal in our department more than a decade ago to reach the top 20, and this year’s ranking by U.S. News & World Report as number 14 in the United States is a further validation of our excellence in the MUSC tripartite mission of patient care, education and research,” Lambert said. “It is a tangible testament to the dedication and work ethic of our incredible faculty—physicians, scientists, audiologists, advanced practice providers, nurses and administrative staff. We are pleased with our recognition by U.S. News & World Report, but equally delighted with the record number of MUSC departments and divisions—adult and pediatric—also recognized. The future of our institution is indeed bright.”
David Soper, M.D., director of MUSC Health’s Division of Obstetric & Gynecologic Specialists, said he credits part of his division’s ranking to teamwork. “Honestly, the reason we are top 50 is the people. It’s the physicians, the nurses, the staff—in the offices, in the operating rooms and in our academic offices—who help us day in and day out, to provide not only high-tech but also high-touch, as in compassionate and careful care. My colleagues love what they do, and it shows. They come to work every day with that wonder of how we can change women’s lives and change what’s possible.”
Soper said another strength is the depth of the division’s multidisciplinary clinical offerings. Of note:
• MUSC Health Bladder & Pelvic Health Program, led by urogynocologists Steven Swift, M.D., and Autumn Edenfield, M.D., who specialize in medical and surgical management of women with urinary incontinence, fecal incontinence and pelvic floor relaxation disorders.
• A minimally-invasive surgery center with experienced physicians in robotic surgeries for benign disease as well as gynecologic malignancies.
• Reproductive infectious disease experts who offer care in all viral and bacterial diseases complicating pregnancy, including HIV and the Zika virus.
• A family planning and early pregnancy failure clinic, headed by Angela Dempsey, M.D., who is specially trained in modern contraceptive technologies.
• Menopausal specialists who provide the latest in care available for women struggling with menopausal symptoms.
But Soper said it’s not just clinical care. He praised ongoing research and translational collaborations. That includes cancer treatments organized through MUSC’s Gynecologic Oncology Program and MUSC’s Hollings Cancer Center. It also includes research unrelated to cancer, such as a uterine fibroid study that uses novel pharmacologic agents to allow women with fibroids to avoid surgery and still manage their symptoms.